Adaptyv Biosystems: Funding, Investors & Team (Sep 2026)
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and nanofluidics.
Adaptyv Biosystems has raised $42.6M across 3 funding rounds on record, the most recent a Series A of $40.0M announced in Aug 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Adaptyv Biosystems Company Profile and Key Stats
Latest funding round on record: Aug 2026.
Adaptyv Biosystems Funding Rounds
Adaptyv Biosystems raised $2.5M in a Pre-Seed announced in Feb 2022.
1.3 years later, an undisclosed round of $110k was announced in Jun 2023.
3.2 years later, a Series A of $40.0M was announced in Aug 2026.
Adaptyv Biosystems Investors
17 investors are recorded in total; the 6 named above are those the record identifies.
Adaptyv Biosystems Founders and Leadership Team
Contact details for the Adaptyv Biosystems team: 3 of 3 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Adaptyv Biosystems Funding Compared to Other Biotechnology Startups
Adaptyv Biosystems' latest round of $40.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Adaptyv Biosystems in Biotechnology and Lausanne
Companies Similar to Adaptyv Biosystems
At Immitra Bio, we are developing a unique genetic medicine platform that combines two of the most powerful…
compliag is providing agile solutions for regulated industries, including the licencing, manufacturing and…
MoonLake Immunotherapeutics is a biopharmaceutical company in the clinical stage that is developing new…
Isospec Analytics SA is a life science company that aims at simplifying molecular identification. We are…
Cria Technologies reinvents cold-chain transport with high-vacuum insulation technology that offers…
Precise Health is a phage therapy platform that specialises in improving and treating bacterial infections to…
AC Immune is a biopharmaceutical company based in Switzerland that is currently in the clinical stage. They…
AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at…
Combioxin SA is clinical-stage biotech company developing innovative anti-virulence drugs to treat severe…
MindMaze is a digital neurotherapeutic platform that provides digital assessments and therapeutics to treat…
Neurosoft Bioelectronics is developing next-generation soft implantable electrodes to interface with the…
Pharvaris is a clinical-stage company working on bringing a new oral bradykinin B2 receptor antagonist to…
Adaptyv Biosystems Funding FAQs
What does Adaptyv Biosystems do?
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and nanofluidics.
How much funding has Adaptyv Biosystems raised?
Adaptyv Biosystems has raised $42.6M across 3 rounds on record. The most recent is a Series A of $40.0M announced in Aug 2026.
When did Adaptyv Biosystems last raise funding?
Adaptyv Biosystems' most recent funding round on record is a Series A of $40.0M, announced in Aug 2026.
Who has invested in Adaptyv Biosystems?
Investors on record for Adaptyv Biosystems include ACE Ventures, Y Combinator, Highland Europe, Founders, Inc., Founderful. FundedIQ records 17 investors in total.
Who founded Adaptyv Biosystems?
FundedIQ lists Daniel Gutierrez (Co-Founder), Moustafa Houmani (Founder) at Adaptyv Biosystems.
Who is the CEO of Adaptyv Biosystems?
Julian Englert is listed as CEO at Adaptyv Biosystems.
Where is Adaptyv Biosystems headquartered?
Adaptyv Biosystems is based in Lausanne, Vaud, Switzerland.
How many employees does Adaptyv Biosystems have?
Adaptyv Biosystems is in the 1-10 employee band.
When was Adaptyv Biosystems founded?
Adaptyv Biosystems was founded in 2020.
How does Adaptyv Biosystems' funding compare to other Biotechnology startups?
Adaptyv Biosystems' latest round of $40.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Adaptyv Biosystems Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Adaptyv Biosystems is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.